There are few areas of the healthcare space that are causing as much excitement, or have as much potential, as CRISPR.

In this live webinar, we asked three experienced commercial leaders about their insights, advice and predictions on the future of this market. Click to watch.

In the US, New Jersey is a life science powerhouse. It’s home to some of the most influential pharma manufacturers in the world. Click to find out some of the latest developments coming from this area.

In this clip, I talk about how acting fast is crucial to securing the very best talent in life sciences. 

In this clip, I discuss the skills and people that are in demand within the life science industry. 

In this clip, I talk about how small companies can beat the larger corporations for talent. They just need to show off what makes them different, that they're people-focused and they can be flexible.

What does AI mean for drug discovery? This question and many others was answered by three AI experts in our latest CM Life Science webinar.

Consistent early detection is considered the 'holy grail' of cancer diagnosis. If you can catch cancer early enough, you can stop it developing. Liquid biopsy could be the key to unlocking that potential.

The diagnostics space is doing crucial work to detect and limit the spread of Covid-19 all over the world – with companies both big and small contributing to the cause

Rapid detection for sepsis is crucial. Every hour this disease goes untreated, the chances of mortality go up by 8%. To learn more about the disease, we spoke to the experts.

We’ve been waiting for the $100 genome for a long time and now it’s here. Check out what our consultants had to say about this big news and other landmark announcements at AGBT 2020.

There’s so much more to the UK biotech scene than just London and Cambridge. In the North, we're surrounded by many fascinating companies who’re innovating and conducting crucial research.

It's humbling to see how the life science community has come together to combat the coronavirus. Here's what's happening in diagnostics.

Innovative and pioneering, Synthego, a provider of synthetic RNA solutions for CRISPR Genome Engineering, are looking to grow their team.

Reported to correct 89% of pathogenic human gene variants, prime gene editing has the potential to target over 75,000 different mutations in treatment.